Kazuyuki Nishinaka, MD

Disclosure information not submitted.

Presentation(s):

• PD02-05: Efficacy and safety of vibegron as adjuvant treatment on refractory neurogenic bladder dysfunction in children with spina bifida

  Friday, May 13, 2022
  7:40 AM – 7:50 AM